Virtual Network's Login.
REMINDER:
THERE ARE ONLY 3 WEEKS LEFT UNTIL THE ABSTRACT SUBMISSION DEADLINE!
Deadline: January 2nd, 2023 (23:59 CET)
About the programme:
The ESH conference on Erythropoiesis control and Ineffective Erythropoiesis, which will held in Paris in March 3rd-5th 2023 aims at providing an education program on basic science related to normal and pathological erythropoiesis and megakaryopoiesis giving opportunities to share experiences in clinical practice.
Erythropoiesis is a continuous process leading to the daily production of 1011 red cells. The bone marrow microenvironment supports and educates the hematopoietic progenitors. Recent advances deeply increase our understanding of erythropoiesis control and its deregulation in pathological conditions thanks to the studies of chromatin organization and post-transcriptional regulatory mechanisms occurring during erythroid cell differentiation.
Ineffective erythropoiesis relies on various mechanisms that may combine in some diseases or demonstrate specificities supporting particular phenotypes and opening the avenue for targeted therapies.
Identifying the causes of treatment resistance and following the dynamics of erythroid response will provide valuable information to improve patients care through the design of innovative clinical trials.
Main scientific topics:
• Metabolism in erythroid cells
• Proteome remodeling and cellular clearance in erythropoiesis
• Fetal globin silencing
• Bone marrow cell expansion and engraftment
• Stressed erythropoiesis in MDS
• Stressed erythropoiesis in haemoglobinopathies and other haemolytic anaemia
• Clinical and diagnosis
• Gene therapy and genome editing
• Pharmacological approaches
The programme will include:
Plenary Sessions - Simultaneous Meet the Experts Sessions
Round Table Discussions - Poster Presentations - Short Oral Communications
Ample time for in-depth discussion
The preliminary programme is available!
For more information, click here!
